CANCER TRIALS AUSTRALIA
🇦🇺Australia
- Country
- 🇦🇺Australia
- Ownership
- -
- Established
- 1993-01-01
- Employees
- -
- Market Cap
- -
A Study of Belimumab in Treating Symptomatic Waldenstroms Macroglobulinaemia
- First Posted Date
- 2010-06-11
- Last Posted Date
- 2012-02-10
- Lead Sponsor
- Cancer Trials Australia
- Target Recruit Count
- 15
- Registration Number
- NCT01142011
- Locations
- 🇦🇺
The Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
🇦🇺Alfred Health, Melbourne, Victoria, Australia
© Copyright 2025. All Rights Reserved by MedPath